[Staging of Hodgkin's disease by laparotomy: therapeutic consequences].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 391512)

Published in Chirurg on August 01, 1979

Authors

R Siewert, H J Castrup, G A Nagel

Articles by these authors

(truncated to the top 100)

Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol (1992) 1.92

[On the appearance of spontaneous tumors in golden hamster colony breed]. Acta Biol Med Ger (1968) 1.39

[Experimental and clinical tests on the mechanism of fundoplication]. Langenbecks Arch Chir (1973) 1.25

[Evidence for tumor immunity in human malignant melanoma]. Schweiz Med Wochenschr (1970) 1.13

Differential gamma-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of gamma-interferon on tumor cell growth. Cancer Res (1985) 1.11

The continuous withdrawal method for the quantitative analysis of the lower oesophageal sphincter (LES) in humans. Eur J Clin Invest (1973) 1.02

Cardiac Na(+)-Ca2+ exchange system in giant membrane patches. Ann N Y Acad Sci (1991) 0.94

Distribution and metabolism of hexadecylphosphocholine in mice. Lipids (1987) 0.94

Aminoglutethimide-induced hematologic toxicity: worldwide experience. Cancer Treat Rep (1985) 0.91

Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum. Scand J Gastroenterol (1984) 0.90

[Fibrin stabilization and fibrinolysis in total wound dehiscence]. Chirurg (1969) 0.90

Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol (1976) 0.89

Motilin effects on gastrointestinal motility and lower esophageal sphincter (LES) pressure in dogs. Scand J Gastroenterol Suppl (1976) 0.87

Tumor necrosis factor (TNF) alpha: control of TNF-sensitivity and molecular mechanisms of TNF-mediated growth inhibition. Blut (1987) 0.86

Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. Int J Cancer (1984) 0.86

Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. Eur J Cancer (1991) 0.86

Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high-dose medroxyprogesterone acetate. Cancer (1984) 0.85

Cooperative Group of Additional Immunoglobulin Therapy in Severe Bacterial Infections: results of a multicenter randomized controlled trial in cases of diffuse fibrinopurulent peritonitis. Klin Wochenschr (1987) 0.84

[Metastasizing thyroid adenoma]. Chirurg (1972) 0.84

Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer. Eur J Cancer Clin Oncol (1986) 0.84

The mixed lymphocyte tumor cell culture and the fluorescein diacetate cytotoxicity test. Two useful methods for the demonstration of cell mediated tumor specific immunity in man. Acta Haematol (1970) 0.84

The interaction of glucagon and pentagastrin on the lower oesophageal sphincter in man and dog. Gut (1973) 0.83

Cell-mediated immunity against malignant melanoma in monozygous twins. Cancer Res (1970) 0.83

Evidence for tumor-specific immunity in human malignant melanoma. Eur J Cancer (1971) 0.83

Identification of lymphocyte subpopulations by simultaneous E-rosette formation and unspecific acid esterase staining. Experientia (1978) 0.82

[Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer]. Dtsch Med Wochenschr (1983) 0.82

The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer. Cancer Chemother Pharmacol (1982) 0.82

[Gastrointestinal hormones and lower esophageal sphincter]. Chirurg (1974) 0.81

[Endoscopic-pneumatic dilation (EPD) for the treatment of achalasia (author's transl)]. Z Gastroenterol (1980) 0.81

Pattern of endogenous lectins in a human epithelial tumor. Cancer Res (1985) 0.81

The motor-stimulating effect of natural motilin on the lower esophageal sphincter fundus, antrum and duodenum in dogs. Digestion (1975) 0.81

[Experimental and clinical studies of the mechanism of fundoplication]. Helv Chir Acta (1974) 0.81

[Immunosuppression: a paraneoplastic syndrome]. Schweiz Med Wochenschr (1971) 0.81

[Pressure curves in the lower esophageal sphincter in man and the influence of gastrin, calcitonin and glucagon]. Dtsch Med Wochenschr (1973) 0.81

Mitomycin-induced haemolysis and renal failure. Lancet (1980) 0.80

[Follow-up of fundoplication (author's transl)]. Langenbecks Arch Chir (1975) 0.80

Suppressed colony formation of peripheral blood lymphocytes in a patient with somatostatinoma. Clin Immunol Immunopathol (1986) 0.80

[Clinical and experimental studies on the efficiency of nifedipine on smooth muscle strips of the esophagus (author's transl)]. Z Gastroenterol (1977) 0.80

[Blood-brain barrier and the penetration of cytostatic drugs]. Klin Wochenschr (1985) 0.80

Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. Cancer Res (1982) 0.79

Aminoglutethimide. Penetration of the blood brain barrier. Invest New Drugs (1986) 0.79

Intra-arterial perfusion therapy with 5-fluorouracil in patients with metastatic colorectal carcinoma and intractable pelvic pain. Recent Results Cancer Res (1983) 0.79

Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: clinical responsiveness to recombinant IFN-alpha correlates with the degree of receptor down-regulation. Int J Cancer (1989) 0.79

Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum. J Clin Lab Immunol (1985) 0.79

[Metastasizing adenocarcinoma from an unknown primary tumor]. Dtsch Med Wochenschr (1984) 0.79

[Morphological and autoradiographic studies of alterations in the samll intestinal mucosa of rats with blind loops]. Virchows Arch A Pathol Pathol Anat (1970) 0.79

Differential expression of endogenous sugar-binding proteins (lectins) in murine tumor model systems with metastatic capacity. Int J Cancer (1987) 0.78

[Operation, intervention, rendezvous maneuver]. Chirurg (2000) 0.78

[Thrombocytosis in malignant tumors]. Schweiz Med Wochenschr (1973) 0.78

Chromatofocusing combined with the ELISA technique. A sensitive method for the analysis of immune complexes. J Immunol Methods (1983) 0.78

Clinical and manometric investigations of the lower esophageal sphincter and its reactivity to pentagastrin in patients with hiatus hernia. LES-pentagastrin-test. Digestion (1975) 0.78

[1st experiences with Adriamycin, a new cytotoxic antibiotic, in combination chemotherapy of malignant tumors]. Schweiz Med Wochenschr (1972) 0.78

Hexadecylphosphocholine (D 18506) in the topical treatment of skin metastases: a phase-I trial. Onkologie (1988) 0.78

[Bromocriptine in chemotherapy-resistant, metastatic breast cancer. Results of the GO-MC-BROMO 2/82 AIO Study]. Onkologie (1988) 0.78

[Chronic granulocytopenia as a main symptom of T gamma-lymphocytosis]. Dtsch Med Wochenschr (1989) 0.77

[Mucin-like carcinoma-associated antigen: sensitivity and specificity in metastatic breast cancer]. Onkologie (1990) 0.77

Characterization of immune complexes detected by the 125I-C1q binding assay in breast cancer. Clin Immunol Immunopathol (1988) 0.77

Effect of ether lipids on mouse granulocyte-macrophage progenitor cells. Cancer Chemother Pharmacol (1989) 0.77

Carbohydrate-binding proteins of tumor lines with different growth properties. II. Changes in their pattern in clones of transformed rat fibroblasts of differing metastatic potential. Cell Tissue Res (1986) 0.77

[Lethal course of anorexia nervosa, alcohol and laxative abuse in a female patient]. Internist (Berl) (1972) 0.77

Biological and biochemical characterization of a somatostatin-producing human carcinoma established by heterotransplantation. Cancer Res (1985) 0.77

[Prophylaxis and therapy of cytostatic-induced skin necrosis]. Onkologie (1980) 0.77

[Carcinoma of the esophagus and cardia]. Internist (Berl) (1977) 0.76

Use of recombinant human granulocyte-macrophage colony stimulating factor in T-lymphocytosis with granulocytopenia. Eur J Haematol (1990) 0.76

[Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study]. Onkologie (1987) 0.76

Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies. Eur J Cancer Clin Oncol (1989) 0.76

Malignant lymphoma in four of five siblings. Int J Cancer (1978) 0.76

Cytotoxic activity of lysophosphatidylcholine analogues on human lymphoma Raji cells. Onkologie (1990) 0.76

Phasic and tonic types of smooth muscle activity in lower oesophageal sphincter and stomach of the dog. Acta Hepatogastroenterol (Stuttg) (1979) 0.76

[Long-term results of the anti-emetic effectiveness of the 5-HT3 antagonist ondansetron]. Onkologie (1990) 0.75

[Gaucher disease and pregnancy]. Z Geburtshilfe Perinatol (1989) 0.75

Carbohydrate-binding proteins of tumor lines with different growth properties. I. Differences in their pattern for three clones of rat fibroblasts transformed with a myeloproliferative sarcoma virus. Cell Tissue Res (1985) 0.75

Phase I study of recombinant human tumor necrosis factor-alpha in patients with advanced malignancies. Mol Biother (1988) 0.75

[The transformation of gamma-tocopherol to alpha-tocopherol in the animal organism; a generational study in rats]. Z Ernahrungswiss (1989) 0.75

[The cancer patient between academic medicine and alternative medicine--therapeutic concepts]. Arch Gynecol Obstet (1995) 0.75

Cancer treatments. Nature (1991) 0.75

[On the suitability of 2 isologous tumor-host systems for chemotherapeutic studies]. Arch Geschwulstforsch (1967) 0.75

[Surgical therapy of struma]. Chirurg (1967) 0.75

[Emergency procedures in duodenal ulcer]. Chirurg (1982) 0.75

The lower oesophageal sphincter in the Zollinger-Ellison syndrome. Ger Med (1973) 0.75

[Blood volume determination in mechanic intestinal obstruction. (A contribution on the problem of volumetry in ileus)]. Wien Z Inn Med (1972) 0.75

[Function of the lower esophageal sphincter in the Zollinger-Ellison syndrome]. Dtsch Med Wochenschr (1973) 0.75

[Indication for fresh blood transfusion]. Chirurg (1967) 0.75

[Change in cell kinetics of gastric surface epithelium in uremia. Autoradiographic study using the percentage of labeled mitoses method]. Beitr Pathol (1972) 0.75

[Hemangiosarcoma of the spleen]. Zentralbl Allg Pathol (1970) 0.75

[Choice of operative procedure in early gastric cancer]. Langenbecks Arch Chir (1982) 0.75

[Surgery of malignant soft tissue tumors]. Chirurg (1983) 0.75

[Classification and therapy of peptic esophageal stenoses]. Langenbecks Arch Chir (1972) 0.75

[Surgical therapy of esophageal erosions and their consequences]. Bruns Beitr Klin Chir (1973) 0.75

[Primary suturing of the biliary pathways]. Chirurg (1971) 0.75

[Generalized congenital listeria monocytogenes infection with fatal outcome (author's transl)]. Geburtshilfe Frauenheilkd (1973) 0.75

[Experimental studies on the function of the lower esophageal sphincter following intrathoracic displacement, myotomy and circular myectomy]. Bruns Beitr Klin Chir (1973) 0.75

[Introduction: gastrointestinal motility]. Z Gastroenterol (1977) 0.75

[Topical aspects of thyroid gland surgery]. Dtsch Med J (1971) 0.75

[Effect of caerulein on the lower esophageal sphincter of man and dog]. Dtsch Med Wochenschr (1973) 0.75

[Postmortal enzyme activities in the infarcted and not infarcted human myocardium]. Med Welt (1973) 0.75

[Manometry and gastro-esophageal closure mechanism. An attempt at evaluation (author's transl)]. Z Gastroenterol (1977) 0.75

[Surgical aspects of peptic esophageal stenosis]. Leber Magen Darm (1972) 0.75

[Pressure diminution of the lower esophageal sphincter through glucagon achalasia]. Dtsch Med Wochenschr (1973) 0.75

[Hiatal hernia, reflux diseases, and reflux esophagitis]. Internist (Berl) (1977) 0.75